Maven Clinic, an online clinic for women and family health, has closed its serie...
Regulators around the world are increasing their scrutiny of medical devices as ...
Scholar Rock Inc has announced that the phase 3 trial of Apitegromab for spinal ...
Johnson & Johnson’s SunRISe-2 study has officially been discontinued. Johnson & ...
In a recent move, Editas sold part of these rights to DRI Healthcare’s subsidiar...
The FDA gave the green light to Bristol Myers Squibb’s much-anticipated schizoph...
Immunai, a biotechnology company based in New York, has partnered with AstraZene...
AbbVie has disclosed that its late-stage monotherapy prospect substantially decr...
Repair Biotechnologies has joined forces with Swiss company Genevant Sciences to...
Biogen and UCB have published a listing of a late-stage clinical trial of dapiro...
Amycretin, Novo Nordisk’s much-anticipated experimental weight-loss drug, was fo...
Vicebio, the British biotech, has closed a $100 million Series B funding round a...
Health technology company PicnicHealth has launched a new product, Virtual Site,...
Results from a mid-stage clinical trial conducted by a small biotechnology compa...
Two medications have been shown to drastically alter the prognosis for the fatal...
Terns Pharmaceuticals’ decision to move away from the liver disease field may tu...
